XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF EQUITY - 3 months ended Mar. 31, 2017 - USD ($)
Series E Cumulative Redeemable Preferred Stock
Preferred Stock
Series E Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series E Cumulative Redeemable Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series F Cumulative Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings
Cumulative dividends and distributions
Noncontrolling Interest in Consolidated Joint Venture
Total
Beginning Balance at Dec. 31, 2016 $ 115,000,000     $ 75,000,000     $ 2,201,000 $ 2,596,620,000 $ 786,901,000 $ (1,092,952,000) $ 49,062,000 $ 2,531,832,000
Beginning Balance (in shares) at Dec. 31, 2016 4,600,000     3,000,000     220,073,140          
Increase (Decrease) in Stockholders' Equity                        
Deferred stock compensation, net             $ 3,000 (1,896,000)       (1,893,000)
Deferred stock compensation, net (in shares)             344,277          
Common stock distributions and distributions payable                   (11,021,000)   (11,021,000)
Preferred stock dividends and dividends payable   $ (1,998,000) $ (1,998,000)   $ (1,209,000) $ (1,209,000)            
Distributions to noncontrolling interest                     (2,325,000) (2,325,000)
Net income                 61,835,000   1,992,000 63,827,000
Ending Balance at Mar. 31, 2017 $ 115,000,000     $ 75,000,000     $ 2,204,000 $ 2,594,724,000 $ 848,736,000 $ (1,107,180,000) $ 48,729,000 $ 2,577,213,000
Ending Balance (in shares) at Mar. 31, 2017 4,600,000     3,000,000     220,417,417